CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Duijnhoven, F. J.B.
Right arrow Articles by van Gils, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Duijnhoven, F. J.B.
Right arrow Articles by van Gils, C. H.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2655-2660, November 2005
© 2005 American Association for Cancer Research

Polymorphisms in the Estrogen Receptor {alpha} Gene and Mammographic Density

Fränzel J.B. van Duijnhoven1, Irene D. Bezemer1, Petra H.M. Peeters1, Mark Roest2, André G. Uitterlinden3, Diederick E. Grobbee1 and Carla H. van Gils1

1 Julius Center for Health Sciences and Primary Care and 2 Research Laboratory of the Department of Clinical Chemistry, University Medical Center, Utrecht, the Netherlands; and 3 Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands

Requests for reprints: Carla H. van Gils, Julius Center for Health Sciences and Primary Care University Medical Center, Utrecht Mail Drop Str. 6.131, P.O. Box 85500, 3508 GA Utrecht, the Netherlands. Phone: 31-30-2503014; Fax: 31-30-2505485. E-mail: C.vanGils{at}umcutrecht.nl

The presence of the PvuII or the XbaI polymorphism in the estrogen receptor {alpha} gene (ESR1, 6q25) has been related to breast cancer risk; however, results are not fully consistent. To further elucidate this relation, we examined these polymorphisms in relation with mammographic density, a measure of dense tissue in the breast, which is strongly associated with breast cancer risk. For this study, 620 participants aged 49 to 68 years were selected from the Prospect-European Prospective Investigation into Cancer and Nutrition cohort. Blood samples, lifestyle– and medical questionnaire data and mammograms were available for these women. Genotyping was done using the TaqMan PCR assay and mammographic density was assessed using a computer-assisted method. Means of mammographic density were compared by ESR1 genotypes and haplotypes. The percentage density was higher in women with one or two copies of the PvuII p allele (means for Pp and pp are 37% and 36%, respectively) than in those with the PP genotype (32%, Ptrend = 0.09). Women with one or two copies of the XbaI x allele had higher mean percentage density (Xx and xx, 36% and 37%, respectively) than those with the XX genotype (31%, Ptrend < 0.01). Haplotype 1 (px) was associated with increased density, whereas haplotype 2 (PX) was associated with decreased density, both suggesting an allele-dose effect (Ptrend = 0.08 and <0.01, respectively). Similar associations were found with absolute density (Ptrend < 0.01). The findings of this study support the view that ESR1 polymorphisms may affect breast cancer risk through differences in breast density.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
C. S. Weickert, A. L. Miranda-Angulo, J. Wong, W. R. Perlman, S. E. Ward, V. Radhakrishna, R. E. Straub, D. R. Weinberger, and J. E. Kleinman
Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia
Hum. Mol. Genet., August 1, 2008; 17(15): 2293 - 2309.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. E. Kelemen, V. S. Pankratz, T. A. Sellers, K. R. Brandt, A. Wang, C. Janney, Z. S. Fredericksen, J. R. Cerhan, and C. M. Vachon
Age-specific Trends in Mammographic Density: The Minnesota Breast Cancer Family Study
Am. J. Epidemiol., May 1, 2008; 167(9): 1027 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Vachon, T. A. Sellers, E. E. Carlson, J. M. Cunningham, C. A. Hilker, R. L. Smalley, D. J. Schaid, L. E. Kelemen, F. J. Couch, and V. S. Pankratz
Strong Evidence of a Genetic Determinant for Mammographic Density, a Major Risk Factor for Breast Cancer
Cancer Res., September 1, 2007; 67(17): 8412 - 8418.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y.-Y. Hsieh, Y.-K. Wang, C.-C. Chang, and C.-S. Lin
Estrogen receptor {alpha}-351 XbaIG and -397 PvuIIC-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma
Mol. Hum. Reprod., February 1, 2007; 13(2): 117 - 122.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. J.B. van Duijnhoven, P. H.M. Peeters, R. M.L. Warren, S. A. Bingham, A. G. Uitterlinden, P. A.H. van Noord, E. M. Monninkhof, D. E. Grobbee, and C. H. van Gils
Influence of Estrogen Receptor {alpha} and Progesterone Receptor Polymorphisms on the Effects of Hormone Therapy on Mammographic Density.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 462 - 467.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.